Clinical Trial

A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity

Completed Phase 3
View on ClinicalTrials.gov →
Summary
The study is being conducted to evaluate the efficacy and safety of HRS-7535 in subjects with overweight or obesity.
Protocol Amendment History 3 changes
critical Trial completed 2026-07-28
critical Primary endpoint(s) modified 2026-07-28
minor Completion pushed: 2026-05 -> 2026-06-12 2026-07-28
Trial Details
NCT Number NCT06904105
Lead Sponsor Shandong Suncadia Medicine Co., Ltd.
Conditions Overweight, Obesity
Enrollment 556 participants
Start Date 2025-04-10
Primary Completion 2026-04-17 (estimated)
Study Completion 2026-06-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-27